Online Program

Coffee consumption, caffeine and self-reported parkinson's disease in the adventist health study-2

Tuesday, November 5, 2013

Nicole Gatto, MPH, PhD, CPH, Epidemiology, Biostatistics and Population Medicine, School of Public Health, Loma Linda University, Loma Linda, CA
Dean Sherzai, MD, Department of Neurology, Loma Linda University Medical Center, Loma Linda, CA
Karen Jaceldo-Siegl, PhD, Adventist Health Study, School of Public Health, Loma Linda University, Loma Linda, CA
Gary Fraser, PhD; MD, Department of Epidemiology, School of Public Health, Loma Linda University, Loma Linda, CA
Epidemiologic studies consistently find inverse associations between Parkinson's disease (PD), coffee drinking and cigarette smoking. However, an independent association between coffee consumption and PD risk has been difficult to assess given the correlation between coffee drinking and smoking. The Adventist Health Study-2 provides an opportunity to study PD while minimizing confounding by smoking, as the cohort consists predominantly of never smokers. A third follow-up questionnaire administered on average 5 years (range 1 – 9) after baseline identified 260 newly reported PD cases (8.2 per 10,000 average annual incidence). Mean age at diagnosis was 72.6 years; 186 (71.5%) reported having been treated for PD within the last 12 months. Of the incident cases, 107 were female (41.2%), 229 (88.1% were non-Hispanic white); 95 (37.1%) had a college education or higher. Four controls were matched to each case based on age (5-year categories), sex and race. 80.9% of cases and 76.7% of controls were never smokers; 4.2% of cases and 15.9% of controls reported consuming some coffee at varying frequencies. In adjusted logistic regression models, any coffee consumption (times per month, week or day) was not associated with decreased PD risk (OR = 1.07, 95% CI = 0.75, 1.52). Frequency of consumption weighted for serving size of coffee or caffeine from all sources (caffeinated tea, chocolate) was also not associated with PD. This study is not supportive of a protective effect of coffee or caffeine in PD while minimizing confounding by smoking. Additional analyses of PD in AHS-2 will merit from the non-smoking makeup of the cohort.

Learning Areas:

Chronic disease management and prevention

Learning Objectives:
Evaluate risk factors for Parkinson's disease while minimizing confounding by smoking.

Keyword(s): Smoking, Chronic Diseases

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: During the last four years, I have been researching Parkinson's disease, first as a post-doctoral fellow and then as faculty member and have been supported by more than one federally grant to do so.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.